104 related articles for article (PubMed ID: 1703165)
1. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of flat revertant cell lines from A-MuLV-transformed fibroblasts.
Glass DJ; Rees-Jones RW; Goff SP
Oncogene Res; 1990; 5(3):175-85. PubMed ID: 2157187
[TBL] [Abstract][Full Text] [Related]
3. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
Keller JR; Ruscetti SK; Ruscetti FW
Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
[TBL] [Abstract][Full Text] [Related]
4. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
Muljo SA; Schlissel MS
Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
[TBL] [Abstract][Full Text] [Related]
5. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
Colledge WH; Gebhardt A; Edge MD; Bell JC
Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
[TBL] [Abstract][Full Text] [Related]
6. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of v-Abl transformation by p53 and p19ARF.
Cong F; Zou X; Hinrichs K; Calame K; Goff SP
Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation within the kinase domain of v-abl gene responsible for temperature-sensitive colony-forming ability in soft agar.
Soma T; Tsukada S; Oka Y; Kishimoto T; Sugiyama H
Virology; 1993 Apr; 193(2):967-70. PubMed ID: 8460498
[TBL] [Abstract][Full Text] [Related]
9. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
10. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl.
Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA
Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879
[TBL] [Abstract][Full Text] [Related]
11. Arrested development: understanding v-abl.
Kerr LD
Bioessays; 1994 Jul; 16(7):453-5. PubMed ID: 7945272
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
[TBL] [Abstract][Full Text] [Related]
13. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
Hines DL
Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Abelson oncogene function by erbstatin analogues.
Kawada M; Tawara J; Tsuji T; Honma Y; Hozumi M; Wang JY; Umezawa K
Drugs Exp Clin Res; 1993; 19(6):235-41. PubMed ID: 8013266
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of the Abelson murine leukemia virus transforming gene.
Wang JY; Prywes R; Baltimore D
Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
[TBL] [Abstract][Full Text] [Related]
16. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
17. Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation.
Rosenberg N
Semin Cancer Biol; 1994 Apr; 5(2):95-102. PubMed ID: 8061334
[TBL] [Abstract][Full Text] [Related]
18. Blast colonies containing hemopoietic progenitor cells can give rise to Abelson virus (A-MuLV)-transformed cell lines.
Wong PM; Chung SW; Raefsky E; Eaves CJ; Nienhuis AW
Exp Hematol; 1988 Jan; 16(1):5-11. PubMed ID: 2446900
[TBL] [Abstract][Full Text] [Related]
19. Transforming pathways activated by the v-Abl tyrosine kinase.
Shore SK; Tantravahi RV; Reddy EP
Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
[TBL] [Abstract][Full Text] [Related]
20. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
